Biogen (BIIB) Tops Q3 EPS by 61c
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $200.77 +0.53%
EPS Growth %: -41.3%
Financial Fact:
Product: 2.54B
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: -41.3%
Financial Fact:
Product: 2.54B
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q3 EPS of $6.31, $0.61 better than the analyst estimate of $5.70. Revenue for the quarter came in at $3.1 billion versus the consensus estimate of $3.03 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
- Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
- Creatd files Form S-1 and reports Q1 2026 financial results
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
